Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Women’s Pavilion at CWCBExpo New York Expands with Emerging Cannabis Entrepreneurs
    Women’s Pavilion at CWCBExpo New York Expands with Emerging Cannabis Entrepreneurs Business
  • A Week-Long Celebration of Global Cinema in NYC
    A Week-Long Celebration of Global Cinema in NYC World News
  • RS Metrics’ Expansion to Europe Led by Environmental and Capital Markets Thought Leader Magnus Billing
    RS Metrics’ Expansion to Europe Led by Environmental and Capital Markets Thought Leader Magnus Billing World News
  • We need to wake up to “dangerous and insidious threat” to the West, says Benedict Rogers
    We need to wake up to “dangerous and insidious threat” to the West, says Benedict Rogers World News
  • Staffing Industry Leader NEXTAFF Opens Kansas City, Kansas, Office
    Staffing Industry Leader NEXTAFF Opens Kansas City, Kansas, Office Business
  • Top Luxury Construction Firm in U.S. Prepares for Growth
    Top Luxury Construction Firm in U.S. Prepares for Growth Business
  • Greater NY Dental Meeting To Feature Myofunctional Therapy Trailblazers
    Greater NY Dental Meeting To Feature Myofunctional Therapy Trailblazers World News
  • Global Aminoglycosides Market Size, Share And Growth Analysis For 2024-2033
    Global Aminoglycosides Market Size, Share And Growth Analysis For 2024-2033 Business
Inmedix appoints Lucy Lu as CCO as it approaches US commercialization.

Inmedix appoints Lucy Lu as CCO as it approaches US commercialization.

Posted on January 24, 2024 By NewsEditor

Inmedix appoints Lucy Lu as CCO as it approaches US commercialization.

Longstanding commercial medtech and diagnostic experience added to the Inmedix executive team

NORMANDY PARK, WA, USA, January 20, 2024 /EINPresswire.com/ — Seattle-based medtech/biotech Inmedix, Inc., developers of immuno-autonomics and cloud-based clinical diagnostics to quantify stress biology with precision, announced today the appointment of Lucy Lu as its Chief Commercial Officer (CCO).

Lucy Lu has more than 25 years of biotech industry experience and has been a consultant to Inmedix since 2020. She most recently served as the President of North America Operations for Syncell, Inc., a biotech startup with an innovative spatial biology platform technology. From 2008 to 2014, Lucy served as SVP of Corporate and Business Development at Crescendo Bioscience. During her six years at Crescendo, she helped raise $90M in venture funding, supported the development and commercialization of a novel rheumatoid arthritis biomarker test, Vectra DA, until Crescendo’s acquisition by Myriad Genetics in 2014.

Prior to joining Crescendo, Lucy was Vice President of the US Chief Technology Office at Roche Diagnostics and was responsible for global technology scouting and assessment to support Roche Diagnostics portfolio growth. In her early career, Lucy worked on drug development at Genentech and BMS before switching to market novel life science tools at Applied Biosystems.

“I am thrilled to join Inmedix as Chief Commercial Officer, and excited to be working with a dynamic team that Dr. Holman has assembled to provide this innovative device to advance patient care,” said Ms. Lu. “By equipping healthcare professionals with this state-of-the-art tool they need, we will empower them to use our real-time data to better monitor their patients’ complex chronic conditions and devise personalized treatment plans to improve health outcomes.”

Inmedix is defining the emerging medical field of immuno-autonomics: the interface between immune function and stress biology, controlled within the brain by the autonomic nervous system (ANS). The natural stress response can beneficially impact immune function in the near term (1). However, chronic activation of the immune system by stress, mediated by the ANS, has been implicated in adversely affecting the onset and severity of autoimmune disease (2). With its CloudHRV™ diagnostic in development, Inmedix intends to provide the leading, precision tool to quantify ANS stress state to support research and clinical care.

“In 2020, Inmedix Board Director and former Crescendo Bioscience President Bernie Tobin introduced me to Lucy,” said Inmedix CEO & Co-founder Andrew J Holman, MD. “Her keen insight, thoughtful leadership and deep experience in the diagnostic field were immediately apparent. As a consultant to Inmedix since that time, her guidance to me and our growing, exceptional team has been pivotal. I could not be more pleased to have her leading our commercial efforts.”

References
1. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve – an integrative interface
between two supersystems: the brain and the immune system. Pharmacol Rev 2000;52:595-
638.
2. Taylor PC, Holman A J. Rheumatoid arthritis and the emergence of immuno-autonomics.
Rheumatology (Oxford). 2019 Dec 1;58(12):2079-2080. doi: 10.1093/rheumatology/kez216. PMID:
31177267.

About Inmedix, Inc. and its subsidiary, Inmedix UK, Ltd.

Seattle-based biotech/medtech Inmedix, Inc. and its subsidiary Inmedix UK, Ltd., are committed to engaging in world class research to discover innovative solutions for pressing healthcare needs related to the impact of stress, modulated within the brain by the autonomic nervous system (ANS). The Inmedix® CloudHRV™ diagnostic system is leading the development of heart rate variability (HRV) as a potentially informative diagnostic, therapeutic, digital health, and health economic tool. ANS profile may be the most overlooked element of personalized, precision medicine.

NOTICE:

This press release contains certain forward-looking statements, including without limitation statements regarding Inmedix’s plans for preclinical studies and product capabilities. You are cautioned that such forward-looking statements are not guarantees of future performance and involve risks and uncertainties inherent in Inmedix’s business which could significantly affect expected results, including without limitation, progress of development, clinical testing and regulatory approval, developments in raw material and personnel costs, and legislative, fiscal, and other regulatory measures. All forward-looking statements are qualified in their entirety by this cautionary statement, and Inmedix undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release. This is not an offer to sell or an offer to purchase securities.

Andrew Holman
Inmedix Inc.
+1 2064125347
email us here

You just read:

News Provided By

January 20, 2024, 22:18 GMT


EIN Presswire’s priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content.
As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone’s Internet News Presswire™,
tries to define some of the boundaries that are reasonable in today’s world. Please see our
Editorial Guidelines
for more information.

Article originally published on www.einpresswire.com as Inmedix appoints Lucy Lu as CCO as it approaches US commercialization.

Business

Post navigation

Previous Post: War Day 553: Hits on Russian Pskov Base and 7 more targets
Next Post: U.S. Hispanic Business Council Celebrates Chairman Roger Williams’ Steadfast Support for American Small Business

Related Posts

  • Gender-Free Kids Clothing Brand StereoType Celebrates 2 Year Anniversary
    Gender-Free Kids Clothing Brand StereoType Celebrates 2 Year Anniversary Business
  • Your Home Sold Guaranteed Realty Takes the Lead in Real Estate Brokerage with Innovative AI-Powered Workshop
    Your Home Sold Guaranteed Realty Takes the Lead in Real Estate Brokerage with Innovative AI-Powered Workshop Business
  • The Architects of Efficiency: Business Optimization Consulting Growth
    The Architects of Efficiency: Business Optimization Consulting Growth Business
  • Bloxtel Showcases World’s First Asymmetric Mobile Network Authentication
    Bloxtel Showcases World’s First Asymmetric Mobile Network Authentication Business
  • Securiport Announces Bronze Sponsorship of The 79th IATA AGM And World Air Transport Summit
    Securiport Announces Bronze Sponsorship of The 79th IATA AGM And World Air Transport Summit Business
  • Greenpeace MENA, Ajman University, and UAE Universities Climate Network Celebrate ‘Wellbeing Economy Award’ Winners
    Greenpeace MENA, Ajman University, and UAE Universities Climate Network Celebrate ‘Wellbeing Economy Award’ Winners Business
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Jul    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Augusta Precious Metals Ranked #1 in Industry ReportAugust 3, 2025
  • The National Space Society Mobilizes for the ‘Day of Action to Save NASA Science’August 3, 2025
  • Fremantle’s Original Productions to Give Away Bored Ape in Celebration of How The World Went Ape$h!t’s Stuff.io ReleaseAugust 3, 2025
  • Christmas Comes in July Thanks to First City Credit Union and KEVANI’s Generous Billboard Space DonationAugust 2, 2025
  • War in Ukraine, Analytics. Day 1243: Why American Aid Will Not Help. Arestovych, Shelest.August 2, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Ang3lina and Feranbanks’ “Tempted 2 Touch” Soars to #7 on Billboard Worldwide Digital Downloads Chart
    Ang3lina and Feranbanks’ “Tempted 2 Touch” Soars to #7 on Billboard Worldwide Digital Downloads Chart World News
  • “Transitioning Furniture Business Online” – Omnichannel Specialists YRC Explain Why
    “Transitioning Furniture Business Online” – Omnichannel Specialists YRC Explain Why Business
  • War Day 307: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 307: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Fleet management market is set to reach a valuation of USD 81.6 billion by 2031, according to SkyQuest Technology.
    Fleet management market is set to reach a valuation of USD 81.6 billion by 2031, according to SkyQuest Technology. World News
  • STEMart Launches New Force Degradation Services to Ensure Drug Stability and Safety
    STEMart Launches New Force Degradation Services to Ensure Drug Stability and Safety Business
  • Excelsior University announces 0,000 in new scholarships
    Excelsior University announces $400,000 in new scholarships World News
  • State Department Announces 28th Experience America Visit to Boston
    State Department Announces 28th Experience America Visit to Boston World News
  • War in Ukraine, Analytics. Day 929: So Negotiations are Finally Going to Happen? Arestovych, Feldman
    War in Ukraine, Analytics. Day 929: So Negotiations are Finally Going to Happen? Arestovych, Feldman World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .